US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Critical Resources Limited (CRR) 銘柄情報

Critical Resources Limited (CRR)

0.007

0.00

(0.00%)

終了 6月12日 3:00PM

Critical Resources Limited (CRR) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.007

( - )

買値

0.007

売値

0.008

出来高

515,723

0.007 日の範囲 0.0075

0.003 52 週間の範囲 0.013

時価総額

前日終値

0.007

始値

0.007

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 2,152,042

発行済株式数

3,194,085,445

配当利回り

PER

-8.76

1 株当たり利益 (EPS)

-0

歳入

-

純利益

-1.95M

Critical Resources Limited engages in the exploration and development of mineral projects in Australia and Canada. It explores for lithium, zinc, lead, copper, silver, and gold deposits. The company’s flagship project is the Mavis Lake Lithium Project located in Ontario, Canada. Critical Resources L... Critical Resources Limited engages in the exploration and development of mineral projects in Australia and Canada. It explores for lithium, zinc, lead, copper, silver, and gold deposits. The company’s flagship project is the Mavis Lake Lithium Project located in Ontario, Canada. Critical Resources Limited was formerly known as Force Commodities Limited and changed its name to Critical Resources Limited in May 2021. The company was incorporated in 2010 and is based in Perth, Australia. 詳細を表示

セクター

Materials

業界

Mining

ウェブサイト

www.criticalresources.com.au

本社

Perth, Australia

設立

2026

Critical Resources Limited is listed in the Materials sector of the オーストラリア証券取引所 with ticker CRR. The last closing price for Critical Resources was AUD0.01. Over the last year, Critical Resources shares have traded in a share price range of AUD 0.003 to AUD 0.013.

Critical Resources currently has 3,194,085,445 shares in issue. The market capitalisation of Critical Resources is AUD22.36 million. Critical Resources has a price to earnings ratio (PE ratio) of -8.76.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.001	-12.5	0.008	0.008	0.007	2084021	0.00740275	DE
4	-0.002	-22.2222222222	0.009	0.009	0.007	1159126	0.00784397	DE
12	-0.001	-12.5	0.008	0.011	0.006	2195986	0.00799416	DE
26	-0.002	-22.2222222222	0.009	0.012	0.006	2836285	0.0087031	DE
52	0.003	75	0.004	0.013	0.003	4124500	0.00797569	DE
156	-0.035	-83.3333333333	0.042	0.063	0.003	3582271	0.01777884	DE
260	-0.024	-77.4193548387	0.031	0.14	0.003	6372470	0.05094086	DE

CRR - Frequently Asked Questions (FAQ)

What is the current Critical Resources Limited share price?

The current share price of Critical Resources Limited is AUD 0.007

How many Critical Resources Limited shares are in issue?

Critical Resources Limited has 3,194,085,445 shares in issue

What is the market cap of Critical Resources Limited?

The market capitalisation of Critical Resources Limited is AUD 22.36M

What is the 1 year trading range for Critical Resources Limited share price?

Critical Resources Limited has traded in the range of AUD 0.003 to AUD 0.013 during the past year

What is the PE ratio of Critical Resources Limited?

The price to earnings ratio of Critical Resources Limited is -8.76

What is the registered address of Critical Resources Limited?

The registered address for Critical Resources Limited is 108 St Georges Terrace, Perth, Western Australia, 6000

What is the Critical Resources Limited website address?

The website address for Critical Resources Limited is www.criticalresources.com.au

Which industry sector does Critical Resources Limited operate in?

Critical Resources Limited operates in the Mining sector

knrorrel

knrorrel 10分前

$PAVS WEEEEEEEEEEEEEEEEEEEEEEEE 🚀🚀🚀🚀🔥🔥🔥🔥🔥🔥🔥🔥🚀

knrorrel

knrorrel 17分前

PAVS and HKIT HKIT too , both should run hard today. 🔥
imho

10thMountain

10thMountain 31分前

Woohoo! I’m loving being an early investor. I’ve owned Fidelity Contra Fund for many years which holds a 5% stake in pre-IPO shares! Any other FCNTX holders here? If so…did you see the CNBC article out today that mentions FCNTX??

TieetCoolee

TieetCoolee 33分前

I am pleased to announce the Nomination of very Highly Respected Jay Clayton, former Chairman of the Securities and Exchange Commission, the former Head of Sullivan & Cromwell, one of the most prominent and successful Law Firms anywhere in the World, and the current United States Attorney for the So

PC retired

PC retired 34分前

I am somewhat surprised that there has been no action from the authorities on this scam, yet. The other scam that I have been following and hopefully helping to expose is the Astra/Holcomb(also on ADVFN) where an FBI raid was carried out ~1year ago and the FBI are actively looking for scammed invest

10thMountain

10thMountain 35分前

10thMountain

10thMountain 35分前

10thMountain

10thMountain 36分前

EMBR Is a very RARE gem. X is going crazy of it. Here’s another X post…

https://x.com/beardtrader1178/status/2065313802606760085?s=46

10thMountain

10thMountain 36分前

EMBR Is a very RARE gem. X is going crazy of it. Here’s another X post…

https://x.com/beardtrader1178/status/2065313802606760085?s=46

CA Market News

CA Market News 43分前

Vertical Data and Quantum eMotion Partner to Bring Quantum Cybersecurity to AI Infrastructure DeploymentsJune 12, 2026 3:00 AM
Newsfile

WALL STREET KID

WALL STREET KID 54分前

$AMC GREAT NEWS! $65 SHORT TERM TARGET!

https://youtu.be/POTxAjR9zXw?si=MhP3WfvvBEVYXiFO

https://x.com/CEOAdam/status/2065056828661080534

CA Market News

CA Market News 58分前

Vertical Data and Quantum eMotion Partner to Bring Quantum Cybersecurity to AI Infrastructure DeploymentsJune 12, 2026 3:00 AM
ACCESS NewswireInitial Pilot Deployment Targeted for 2026 Across Vertical Data's GPU Cluster and Edge Data Center Pipeline

US Market News

US Market News 58分前

AbbVie Presents New Data at EHA 2026 Congress for VENCLEXTA®/VENCLYXTO® (venetoclax) in First-Line Chronic Lymphocytic Leukemia Highlighting Long-Term Treatment Outcomes for Patients: Nine-Year ResultsJune 12, 2026 3:00 AM
PR Newswire (US) class="legen

US Market News

US Market News 58分前

AbbVie Presents New Data at EHA 2026 Congress for VENCLEXTA®/VENCLYXTO® (venetoclax) in First-Line Chronic Lymphocytic Leukemia Highlighting Long-Term Treatment Outcomes for Patients: Nine-Year ResultsJune 12, 2026 3:00 AM
PR Newswire (US) class="legen

sharkey1

sharkey1 1時間前

So we wait a year, or Accord scores the patent and Elite gets Tentative approval
then things might change .

iHub News

iHub News 1時間前

SpaceX Secures $75 Billion Ahead of Historic Market DebutJune 12, 2026 2:45 AM
IH Market News SpaceX (NASDAQ:

sharkey1

sharkey1 1時間前

THX, very confusing,
google says
None of these products have yet been approved by the FDA, and Elite therefore does not yet market any products. Elite Labs also engages in contract research ...Read more

no harm no foul
If they went to trial now, it would probly t

Libertas

Libertas 1時間前

Thanks for sharing that, too bad most will write it off as nonsense.

🐻

IH Admin [Shelly]

IH Admin [Shelly] 1時間前

Looks like your computer tried to login you in with your gmail account and it accidentally created a new alias.

Nightdaytrader

Nightdaytrader 1時間前

Split T, next Friday is federal holiday and I believe markets are closed.

Nd9

God Bless America

God Bless America 2時間前

Here I am. From 44 in 2008 to 62 now. So frustrated !

Split T

Split T 2時間前

Just a friendly reminder that next Fiday June 19th is Quadruple. Witching Day, IMVHO we are going to see some crazy trading next week and due to the latest news I'm thinking we will be over $15.30 at close next Friday with volume in excess of 8 million shares according to my William Allen Getty.

God Bless America

God Bless America 2時間前

No IPO for FNMA, FMCC. Just relist and do Second Public Offering.

God Bless America

God Bless America 2時間前

No IPO for FNMA, FMCC. Just relist and do Second Public Offering

Critical Resources

Intelgenx Technologies

Horizons Active Emerging...

Pure Extracts Technologies

Fidelity Nasdaq Composite

BlockQuarry (ID)

Ls 3x Long South Korea Etp

Sunrise Energy Metals (QX)

Ubs Etfs Plc - Map Bal 7...

Goldstorm Metals

Agf Canadian Dividend In...

Mindmaze Therapeutics (QB)

Lamda Development SA Con... (PK)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。